{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:31:29Z","timestamp":1794951089971,"version":"4.9.1"},"reference-count":55,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,11,13]],"date-time":"2002-11-13T00:00:00Z","timestamp":1037145600000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunological Reviews"],"published-print":{"date-parts":[[2002,10]]},"abstract":"<jats:p><jats:bold>Summary:<\/jats:bold> The immune repertoire contains T cells and B cells that can recognize autologous cancer cells. This repertoire is directed against self, and in some cases altered self (mutations). Priming immune responses against self antigens can be difficult. Strategies are presented using altered self to elicit immunity against self in poorly immunogenic tumor models. Mechanisms underlying immunity to self antigens on cancer cells show that the immune system can use diverse strategies for cancer immunity, in both the immunization and the effector phases. CD4<jats:sup>+<\/jats:sup> T cells are typically, but not always, required for immunization. The effector phase of tumor immunity can involve cytotoxic T cells, macrophages with activating Fc receptors, and\/or killer domain molecules. This diversity in the effector phase is observed even when immunizing with conserved paralogs. A consequence of tumor immunity is potentially autoimmunity, which may be undesirable. Autoimmunity uses similar mechanisms as tumor immunity, but tumor immunity and autoimmunity can uncouple. These studies open up strategies for active immunization against cancer.<\/jats:p>","DOI":"10.1034\/j.1600-065x.2002.18811.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T02:35:09Z","timestamp":1047436509000},"page":"122-135","source":"Crossref","is-referenced-by-count":62,"title":["Multiple pathways to tumor immunity and concomitant autoimmunity"],"prefix":"10.1111","volume":"188","author":[{"given":"Mary Jo","family":"Turk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jedd D.","family":"Wolchok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Guevara\u2010Patino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie M.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan N.","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,11,13]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.1.1"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7652577"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.5.757"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5418.1351"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.9.1617"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.12.1793"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1840703"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20000701)87:1<55::AID-IJC8>3.0.CO;2-J"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.2.1153"},{"key":"e_1_2_10_11_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.191.4.625","article-title":"Identification of NY\u2010ESO\u20101 epitopes presented by human histocompatibility antigen (HLA)\u2010DRB4*0101\u20130103 and recognized by CD4(+) T lymphocytes of patients with NY\u2010ESO\u20101\u2010expressing melanoma","volume":"191","author":"Jager E","year":"2000","journal-title":"J Exp Med"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.5.1914"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ge.03.120169.001413"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.156.6.1755"},{"key":"e_1_2_10_16_2","first-page":"421","article-title":"Humoral immune responses to tumor\u2010associated carbohydrate antigens","volume":"2","author":"Lloyd KO","year":"1991","journal-title":"Semin Cancer Biol"},{"key":"e_1_2_10_17_2","first-page":"16","article-title":"Existent T\u2010cell and antibody immunity to HER\u20102\/neu protein in patients with breast cancer","volume":"54","author":"Disis ML","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.18.7159"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.165.3.812"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.7.4260"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.5.1036"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910530407"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910480312"},{"key":"e_1_2_10_24_2","first-page":"2315","article-title":"Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype","volume":"7","author":"Albino AP","year":"1992","journal-title":"Oncogene"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.171.4.1375"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.6.2207"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12460906"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.3.1005"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.14.6458"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199804)28:04<1143::AID-IMMU1143>3.0.CO;2-K"},{"key":"e_1_2_10_31_2","first-page":"909s","article-title":"Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations","volume":"7","author":"Yamshchikov G","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_32_2","first-page":"1837","article-title":"A melanosomal membrane protein is a cell surface target for melanoma therapy","volume":"2","author":"Takechi Y","year":"1996","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.5.1609"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.2.652"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/74704"},{"key":"e_1_2_10_36_2","first-page":"9","article-title":"Alternative roles for IFN\u2010gamma in the immune response to DNA vaccines encoding related melanosomal antigens","volume":"1","author":"Wolchok J","year":"2001","journal-title":"Cancer Immunity"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.25.14809"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4004"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00327-8"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.9.1553"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.11.1717"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2000.107421"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.4.1242"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.10.1636"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115276"},{"key":"e_1_2_10_46_2","first-page":"77","article-title":"Immunization of melanoma patients with BEC2\u2010keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti\u2010GD3 ganglioside antibodies","volume":"5","author":"Yao TJ","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_47_2","first-page":"679","article-title":"Immunization of melanoma patients with BEC2 anti\u2010idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant","volume":"2","author":"McCaffery M","year":"1996","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_48_2","first-page":"1319","article-title":"Long survival of patients with small cell lung cancer after adjuvant treatment with the anti\u2010idiotypic antibody BEC2 plus Bacillus Calmette\u2010Guerin","volume":"5","author":"Grant SC","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/ssu.2980050608"},{"key":"e_1_2_10_50_2","first-page":"2731","article-title":"Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases","volume":"51","author":"Berd D","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_10_51_2","first-page":"5948","article-title":"Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine","volume":"52","author":"Bystryn JC","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.2.489"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20000801)87:3<391::AID-IJC13>3.0.CO;2-K"},{"key":"e_1_2_10_54_2","first-page":"967","article-title":"T\u2010cell responses against tyrosinase 368\u2010376(370D) peptide in HLA(*)A0201(+) melanoma patients: randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony\u2010stimulating factor, and QS\u201021 as immunological adjuvants","volume":"8","author":"Schaed SG","year":"2002","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00144-3"},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/35047123"}],"container-title":["Immunological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-065X.2002.18811.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-065X.2002.18811.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-065X.2002.18811.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:29:52Z","timestamp":1697506192000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-065X.2002.18811.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["10.1034\/j.1600-065X.2002.18811.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-065x.2002.18811.x","archive":["Portico"],"relation":{},"ISSN":["0105-2896","1600-065X"],"issn-type":[{"value":"0105-2896","type":"print"},{"value":"1600-065X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}